skip to main content
Idioma:
Refinado por: Nome da Publicação: Blood remover assunto: Hematology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Randomized phase 2 trial of ixazomib and dexamethasone in relapsed multiple myeloma not refractory to bortezomib
Randomized phase 2 trial of ixazomib and dexamethasone in relapsed multiple myeloma not refractory to bortezomib
Material Type:
Artigo 		Adicionar ao Meu Espaço

Randomized phase 2 trial of ixazomib and dexamethasone in relapsed multiple myeloma not refractory to bortezomib

Kumar, Shaji K. ; LaPlant, Betsy R. ; Reeder, Craig B. ; Roy, Vivek ; Halvorson, Alese E. ; Buadi, Francis ; Gertz, Morie A. ; Bergsagel, P. Leif ; Dispenzieri, Angela ; Thompson, Melanie A. ; Crawley, Jamie ; Kapoor, Prashant ; Mikhael, Joseph ; Stewart, Keith ; Hayman, Suzanne R. ; Hwa, Yi L. ; Gonsalves, Wilson ; Witzig, Thomas E. ; Ailawadhi, Sikander ; Dingli, David ; Go, Ronald S. ; Lin, Yi ; Rivera, Candido E. ; Rajkumar, S. Vincent ; Lacy, Martha Q.

Blood, 2016-11, Vol.128 (20), p.2415-2422 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
2
Phase 2 study of subcutaneous omacetaxine mepesuccinate after TKI failure in patients with chronic-phase CML with T315I mutation
Phase 2 study of subcutaneous omacetaxine mepesuccinate after TKI failure in patients with chronic-phase CML with T315I mutation
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase 2 study of subcutaneous omacetaxine mepesuccinate after TKI failure in patients with chronic-phase CML with T315I mutation

Cortes, Jorge ; Lipton, Jeff H. ; Rea, Delphine ; Digumarti, Raghunadharao ; Chuah, Charles ; Nanda, Nisha ; Benichou, Annie-Claude ; Craig, Adam R. ; Michallet, Mauricette ; Nicolini, Franck E. ; Kantarjian, Hagop

Blood, 2012-09, Vol.120 (13), p.2573-2580 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
3
Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome
Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome
Material Type:
Artigo 		Adicionar ao Meu Espaço

Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome

Maciejewski, Jaroslaw P. ; Follmann, Dean ; Nakamura, Ryotaro ; Saunthararajah, Yogen ; Rivera, Candido E. ; Simonis, Toni ; Brown, Kevin E. ; Barrett, John A. ; Young, Neal S.

Blood, 2001-12, Vol.98 (13), p.3513-3519 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
4
In vitro and in vivo evidence of PNH cell sensitivity to immune attack after nonmyeloablative allogeneic hematopoietic cell transplantation
In vitro and in vivo evidence of PNH cell sensitivity to immune attack after nonmyeloablative allogeneic hematopoietic cell transplantation
Material Type:
Artigo 		Adicionar ao Meu Espaço

In vitro and in vivo evidence of PNH cell sensitivity to immune attack after nonmyeloablative allogeneic hematopoietic cell transplantation

Takahashi, Yoshiyuki ; McCoy, J. Philip Jr ; Carvallo, Cristian ; Rivera, Candido ; Igarashi, Takehito ; Srinivasan, Ramaprasad ; Young, Neal S. ; Childs, Richard W.

Blood, 2004-02, Vol.103 (4), p.1383-1390 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.